Pentose Phosphate Pathway and NADPH: Biochemical Roles and Clinical Relevance

Pentose Phosphate Pathway (PPP)

Overview

The Pentose Phosphate Pathway (PPP), also known as the hexose monophosphate shunt, is a metabolic pathway parallel to glycolysis that occurs in the cytosol of cells. It serves two primary functions: the generation of NADPH for reductive biosynthesis and the production of ribose 5-phosphate for nucleotide synthesis. The pathway consists of an irreversible oxidative phase and a reversible nonoxidative phase involving sugar-phosphate interconversions.

• Oxidative phase: Converts glucose 6-phosphate to ribulose 5-phosphate, producing CO2 and NADPH.

• Nonoxidative phase: Interconverts sugars of various lengths, linking PPP to glycolysis and nucleotide synthesis.

• No ATP is directly consumed or produced in the pathway.

Oxidative Phase of PPP

Irreversible Oxidative Reactions

The oxidative portion of the PPP consists of three irreversible reactions that generate ribulose 5-phosphate, CO2, and two molecules of NADPH per glucose 6-phosphate oxidized. This phase is especially active in tissues with high demand for NADPH, such as the liver, adipose tissue, lactating mammary glands, adrenal cortex, and red blood cells.

• Key products: Ribulose 5-phosphate, CO2, and NADPH.

• Major tissues: Liver (fatty acid and cholesterol synthesis), adrenal cortex, ovaries, placenta, testes (steroid hormone synthesis), and RBCs (glutathione reduction).

Glucose 6-Phosphate Dehydrogenation

The first and rate-limiting step is catalyzed by glucose 6-phosphate dehydrogenase (G6PD):

• Reaction: Glucose 6-phosphate + NADP+ → 6-phosphoglucono-δ-lactone + NADPH + H+

• Regulation: NADPH is a potent competitive inhibitor of G6PD. High NADPH/NADP+ ratio inhibits the enzyme; increased demand for NADPH lowers this ratio, increasing pathway flux.

Equation:

$\text{Glucose 6-phosphate} + \text{NADP}^+ \rightarrow 6\text{-phosphoglucono-}\delta\text{-lactone} + \text{NADPH} + H^+$

Ribulose 5-Phosphate Formation

• 6-Phosphogluconolactone is hydrolyzed by 6-phosphogluconolactone hydrolase to 6-phosphogluconate.

• 6-Phosphogluconate is decarboxylated by 6-phosphogluconate dehydrogenase to ribulose 5-phosphate, CO2, and NADPH.

Equation:

$6\text{-Phosphogluconate} + \text{NADP}^+ \rightarrow \text{Ribulose 5-phosphate} + \text{CO}_2 + \text{NADPH}$

Nonoxidative Phase of PPP

Reversible Nonoxidative Reactions

The nonoxidative reactions occur in all cell types and allow the interconversion of sugars with three to seven carbons. These reactions are catalyzed by transketolase and transaldolase and link the PPP to glycolysis and nucleotide synthesis.

• Functions: Convert ribulose 5-phosphate to ribose 5-phosphate (for nucleotide synthesis) or to glycolytic intermediates (fructose 6-phosphate, glyceraldehyde 3-phosphate).

• Direction depends on cellular needs: If NADPH is needed more than ribose 5-phosphate, sugars are recycled to glycolysis; if ribose 5-phosphate is needed, it is synthesized from glycolytic intermediates.

NADPH: Structure and Functions

Structure of NADPH

Nicotinamide adenine dinucleotide phosphate (NADPH) differs from NADH by the presence of a phosphate group on the 2' position of the ribose ring. This allows NADPH to interact with specific enzymes involved in reductive biosynthesis and antioxidant defense.

Major Uses of NADPH

• Reductive biosynthesis: Fatty acid, cholesterol, and steroid hormone synthesis.

• Antioxidant defense: Regeneration of reduced glutathione (G-SH) for detoxification of reactive oxygen species (ROS).

• Cytochrome P450 monooxygenase reactions: Drug metabolism, bile acid synthesis, and vitamin D activation.

• Phagocytosis: Generation of superoxide and other ROS for microbial killing in neutrophils and macrophages.

• Nitric oxide synthesis: NADPH is required for nitric oxide synthase activity.

Reductive Biosynthesis

NADPH is a high-energy electron donor used in reductive biosynthetic reactions (anabolism), such as fatty acid and cholesterol synthesis. Unlike NADH, which donates electrons to the electron transport chain for ATP production, NADPH is used directly in biosynthetic pathways.

• Example: Fatty acid synthesis in the liver and adipose tissue requires NADPH as a reducing agent.

Antioxidant Defense and Hydrogen Peroxide Reduction

Role in Detoxification of Reactive Oxygen Species (ROS)

Hydrogen peroxide (H2O2) and other ROS are byproducts of aerobic metabolism and can damage DNA, proteins, and lipids. Cells use several mechanisms to minimize ROS toxicity, with NADPH playing a central role.

• Glutathione system: Reduced glutathione (G-SH) detoxifies H2O2 via glutathione peroxidase. Oxidized glutathione (G-S-S-G) is regenerated to G-SH by glutathione reductase, using NADPH as the electron donor.

• Other antioxidants: Superoxide dismutase, catalase, vitamin E, and β-carotene also contribute to ROS defense.

Equation:

$2\text{G-SH} + H_2O_2 \xrightarrow{\text{glutathione peroxidase}} G-S-S-G + 2H_2O$

$G-S-S-G + NADPH + H^+ \xrightarrow{\text{glutathione reductase}} 2\text{G-SH} + NADP^+$

Cytochrome P450 Monooxygenase System

The cytochrome P450 (CYP) monooxygenase system uses NADPH to provide reducing equivalents for the hydroxylation of substrates, including steroid hormones, bile acids, vitamin D, and xenobiotics (drugs, toxins).

• Mitochondrial CYP system: Involved in steroid hormone and vitamin D synthesis.

• Microsomal CYP system (smooth ER): Involved in detoxification of foreign compounds and drug metabolism.

• Hydroxylation: Increases solubility of hydrophobic compounds, facilitating excretion.

Phagocytosis and Microbial Killing

Phagocytic cells (neutrophils, monocytes, macrophages) use NADPH to generate ROS for killing ingested microbes. This process is known as the respiratory burst.

• NADPH oxidase: Uses NADPH to reduce O2 to superoxide (O2•–).

• Superoxide dismutase: Converts superoxide to H2O2.

• Myeloperoxidase: Uses H2O2 and Cl– to form hypochlorous acid (HOCl), a potent bactericidal agent.

Nitric Oxide (NO) Synthesis

Nitric oxide (NO) is a signaling molecule produced from arginine, O2, and NADPH by nitric oxide synthase (NOS). NO causes vasodilation, acts as a neurotransmitter, and has roles in immune defense.

• eNOS and nNOS: Constitutive, Ca2+-calmodulin dependent, produce low levels of NO for vascular and neural signaling.

• iNOS: Inducible, Ca2+-independent, produces large amounts of NO in response to inflammatory stimuli.

• NO mechanism: Activates guanylyl cyclase, increasing cGMP, leading to smooth muscle relaxation.

Equation:

$\text{Arginine} + O_2 + NADPH \xrightarrow{\text{NOS}} \text{Citrulline} + NO + NADP^+$

Glucose 6-Phosphate Dehydrogenase (G6PD) Deficiency

Clinical Features

G6PD deficiency is an X-linked hereditary disorder characterized by hemolytic anemia due to impaired detoxification of ROS in red blood cells (RBCs). RBCs rely solely on the PPP for NADPH production, as they lack mitochondria.

• Triggers: Oxidant drugs (antibiotics, antimalarials, antipyretics), infections, and fava bean ingestion (favism).

• Pathophysiology: Inability to regenerate reduced glutathione leads to oxidative damage, Heinz body formation, and hemolysis.

• Genetics: Multiple G6PD variants exist, with severity correlating to residual enzyme activity.

• Protective effect: G6PD deficiency confers resistance to Plasmodium falciparum malaria.

Table: G6PD Deficiency Variants and Clinical Severity

Class	Enzyme Activity	Clinical Features
I (most severe)	Very low/absent	Chronic non-spherocytic hemolytic anemia, even without stress
II	Low	Hemolysis with stress (drugs, infection, fava beans)
III	Moderately reduced	Hemolysis only with significant oxidative stress
IV/V	Normal or increased	No clinical symptoms

Summary Table: Key Functions of NADPH

Function	Pathway/Process	Example Tissue/Cell
Reductive biosynthesis	Fatty acid, cholesterol, steroid synthesis	Liver, adipose, adrenal cortex
Antioxidant defense	Glutathione reduction	Red blood cells
Detoxification	Cytochrome P450 system	Liver, kidney
Phagocytosis	Respiratory burst (NADPH oxidase)	Neutrophils, macrophages
Nitric oxide synthesis	Nitric oxide synthase	Endothelial cells, neurons, macrophages

Key Points

• The PPP is essential for generating NADPH and ribose 5-phosphate.

• NADPH is required for reductive biosynthesis, antioxidant defense, and specialized cellular functions.

• G6PD deficiency impairs the ability of RBCs to handle oxidative stress, leading to hemolytic anemia.

• PPP activity is regulated by the cellular NADPH/NADP+ ratio and tissue-specific demands.